{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:13:41Z","timestamp":1780550021152,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T00:00:00Z","timestamp":1447804800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["5409"],"award-info":[{"award-number":["5409"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00277-015-2553-2","type":"journal-article","created":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T19:01:41Z","timestamp":1447786901000},"page":"11-18","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Prognostic value of interim and end-of-treatment FDG-PET in follicular lymphoma: a systematic review"],"prefix":"10.1007","volume":"95","author":[{"given":"Hugo J. A.","family":"Adams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger A. J.","family":"Nievelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Kwee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,18]]},"reference":[{"issue":"Suppl 3","key":"2553_CR1","doi-asserted-by":"crossref","first-page":"iii76","DOI":"10.1093\/annonc\/mdu200","volume":"25","author":"M Dreyling","year":"2014","unstructured":"Dreyling M, Ghielmini M, Marcus R, Salles G, Vitolo U, Ladetto M (2014) Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol 25(Suppl 3):iii76\u201382","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"5","key":"2553_CR2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ et al (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25(5):579\u2013586","journal-title":"J Clin Oncol"},{"issue":"27","key":"2553_CR3","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","volume":"32","author":"SF Barrington","year":"2014","unstructured":"Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Mueller SP et al (2014) Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 32(27):3048\u20133058","journal-title":"J Clin Oncol"},{"issue":"27","key":"2553_CR4","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059\u20133068","journal-title":"J Clin Oncol"},{"issue":"4","key":"2553_CR5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","volume":"158","author":"JA Hayden","year":"2013","unstructured":"Hayden JA, van der Windt DA, Cartwright JL, Cote P, Bombardier C (2013) Assessing bias in studies of prognostic factors. Ann Intern Med 158(4):280\u2013286","journal-title":"Ann Intern Med"},{"issue":"8","key":"2553_CR6","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s12149-014-0874-1","volume":"28","author":"Z Lu","year":"2014","unstructured":"Lu Z, Lin M, Downe P, Chong S, Ling S (2014) The prognostic value of mid- and post-treatment [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET) in indolent follicular lymphoma. Ann Nucl Med 28(8):805\u2013811","journal-title":"Ann Nucl Med"},{"issue":"2","key":"2553_CR7","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/annonc\/mdt562","volume":"25","author":"S Luminari","year":"2014","unstructured":"Luminari S, Biasoli I, Versari A, Rattotti S, Bottelli C, Rusconi C et al (2014) The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL). Ann Oncol 25(2):442\u2013447","journal-title":"Ann Oncol"},{"issue":"11","key":"2553_CR8","doi-asserted-by":"crossref","first-page":"E273","DOI":"10.1002\/ajh.23540","volume":"88","author":"PL Zinzani","year":"2013","unstructured":"Zinzani PL, Pellegrini C, Broccoli A, Casadei B, Argnani L, Pileri S (2013) Fludarabine-mitoxantrone-rituximab regimen in untreated intermediate\/high-risk follicular non-Hodgkin's lymphoma: experience on 142 patients. Am J Hematol 88(11):E273\u2013276","journal-title":"Am J Hematol"},{"issue":"35","key":"2553_CR9","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1200\/JCO.2012.43.0934","volume":"30","author":"J Dupuis","year":"2012","unstructured":"Dupuis J, Berriolo-Riedinger A, Julian A, Brice P, Tychyj-Pinel C, Tilly H et al (2012) Impact of [(18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS. J Clin Oncol 30(35):4317\u20134322","journal-title":"J Clin Oncol"},{"issue":"23","key":"2553_CR10","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2011.35.0736","volume":"29","author":"J Trotman","year":"2011","unstructured":"Trotman J, Fournier M, Lamy T, Seymour JF, Sonet A, Janikova A et al (2011) Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants. J Clin Oncol 29(23):3194\u20133200","journal-title":"J Clin Oncol"},{"issue":"12","key":"2553_CR11","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s00259-010-1539-5","volume":"37","author":"L Dortz Le","year":"2010","unstructured":"Le Dortz L, De Guibert S, Bayat S, Devillers A, Houot R, Rolland Y et al (2010) Diagnostic and prognostic impact of 18F-FDG PET\/CT in follicular lymphoma. Eur J Nucl Med Mol Imaging 37(12):2307\u20132314","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"2553_CR12","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1080\/10428190701422059","volume":"48","author":"S Bishu","year":"2007","unstructured":"Bishu S, Quigley JM, Bishu SR, Olsasky SM, Stem RA, Shostrom VK et al (2007) Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma. Leuk Lymphoma 48(8):1548\u20131555","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"2553_CR13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3816\/CLM.2007.n.005","volume":"7","author":"PL Zinzani","year":"2007","unstructured":"Zinzani PL, Musuraca G, Alinari L, Fanti S, Tani M, Stefoni V et al (2007) Predictive role of positron emission tomography in the outcome of patients with follicular lymphoma. Clin Lymphoma Myeloma 7(4):291\u2013295","journal-title":"Clin Lymphoma Myeloma"},{"issue":"5","key":"2553_CR14","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","volume":"104","author":"P Solal-Celigny","year":"2004","unstructured":"Solal-Celigny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R et al (2004) Follicular lymphoma international prognostic index. Blood 104(5):1258\u20131265","journal-title":"Blood"},{"issue":"Suppl 7","key":"2553_CR15","doi-asserted-by":"crossref","first-page":"vii78","DOI":"10.1093\/annonc\/mds273","volume":"23","author":"H Tilly","year":"2012","unstructured":"Tilly H, Vitolo U, Walewski J, da Silva MG, Shpilberg O, Andre M et al (2012) Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii78\u201382","journal-title":"Ann Oncol"},{"issue":"8","key":"2553_CR16","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/annonc\/mdt137","volume":"24","author":"S Luminari","year":"2013","unstructured":"Luminari S, Biasoli I, Arcaini L, Versari A, Rusconi C, Merli F et al (2013) The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi. Ann Oncol 24(8):2108\u20132112","journal-title":"Ann Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2553-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-015-2553-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2553-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T15:06:45Z","timestamp":1553612805000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-015-2553-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,18]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["2553"],"URL":"https:\/\/doi.org\/10.1007\/s00277-015-2553-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,18]]}}}